nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—ADRA2A—type 2 diabetes mellitus	0.238	0.685	CbGaD
Lurasidone—CYP3A4—type 2 diabetes mellitus	0.109	0.315	CbGaD
Lurasidone—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0795	0.202	CbGbCtD
Lurasidone—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0554	0.14	CbGbCtD
Lurasidone—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0382	0.0969	CbGbCtD
Lurasidone—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0365	0.0927	CbGbCtD
Lurasidone—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0365	0.0927	CbGbCtD
Lurasidone—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0337	0.0854	CbGbCtD
Lurasidone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0175	0.0443	CbGbCtD
Lurasidone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0156	0.0395	CbGbCtD
Lurasidone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0142	0.0361	CbGbCtD
Lurasidone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0124	0.0315	CbGbCtD
Lurasidone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0112	0.0285	CbGbCtD
Lurasidone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00852	0.0216	CbGbCtD
Lurasidone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00817	0.0207	CbGbCtD
Lurasidone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00817	0.0207	CbGbCtD
Lurasidone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00773	0.0196	CbGbCtD
Lurasidone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00576	0.0146	CbGbCtD
Lurasidone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00527	0.0134	CbGbCtD
Lurasidone—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00397	0.105	CbGeAlD
Lurasidone—HTR2A—arteriole—type 2 diabetes mellitus	0.00389	0.103	CbGeAlD
Lurasidone—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00267	0.0709	CbGeAlD
Lurasidone—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00248	0.0658	CbGeAlD
Lurasidone—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.00193	0.0512	CbGeAlD
Lurasidone—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00167	0.0442	CbGeAlD
Lurasidone—HTR2A—hindlimb—type 2 diabetes mellitus	0.00154	0.0409	CbGeAlD
Lurasidone—HTR7—artery—type 2 diabetes mellitus	0.00152	0.0402	CbGeAlD
Lurasidone—HTR7—nerve—type 2 diabetes mellitus	0.0015	0.0399	CbGeAlD
Lurasidone—DRD2—nerve—type 2 diabetes mellitus	0.00142	0.0377	CbGeAlD
Lurasidone—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.00141	0.0375	CbGeAlD
Lurasidone—HTR7—endothelium—type 2 diabetes mellitus	0.00128	0.034	CbGeAlD
Lurasidone—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.0012	0.0319	CbGeAlD
Lurasidone—HTR2A—artery—type 2 diabetes mellitus	0.000945	0.0251	CbGeAlD
Lurasidone—HTR2A—nerve—type 2 diabetes mellitus	0.000937	0.0249	CbGeAlD
Lurasidone—HTR2A—endothelium—type 2 diabetes mellitus	0.000798	0.0212	CbGeAlD
Lurasidone—Ziprasidone—ADRA2A—type 2 diabetes mellitus	0.000724	0.325	CrCbGaD
Lurasidone—Ziprasidone—HTR2C—type 2 diabetes mellitus	0.000666	0.299	CrCbGaD
Lurasidone—DRD2—retina—type 2 diabetes mellitus	0.000588	0.0156	CbGeAlD
Lurasidone—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000551	0.0146	CbGeAlD
Lurasidone—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000539	0.0143	CbGeAlD
Lurasidone—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000534	0.0142	CbGeAlD
Lurasidone—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000526	0.014	CbGeAlD
Lurasidone—HTR7—kidney—type 2 diabetes mellitus	0.000515	0.0137	CbGeAlD
Lurasidone—Ziprasidone—CYP1A2—type 2 diabetes mellitus	0.000503	0.226	CrCbGaD
Lurasidone—ADRA2C—kidney—type 2 diabetes mellitus	0.000473	0.0126	CbGeAlD
Lurasidone—ADRA2C—pancreas—type 2 diabetes mellitus	0.00047	0.0125	CbGeAlD
Lurasidone—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000461	0.0122	CbGeAlD
Lurasidone—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000427	0.0113	CbGeAlD
Lurasidone—HTR2A—retina—type 2 diabetes mellitus	0.000388	0.0103	CbGeAlD
Lurasidone—ADRA2A—pancreas—type 2 diabetes mellitus	0.000375	0.00996	CbGeAlD
Lurasidone—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000368	0.00976	CbGeAlD
Lurasidone—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000341	0.00904	CbGeAlD
Lurasidone—Ziprasidone—CYP3A4—type 2 diabetes mellitus	0.000333	0.15	CrCbGaD
Lurasidone—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000328	0.00871	CbGeAlD
Lurasidone—HTR7—liver—type 2 diabetes mellitus	0.000326	0.00864	CbGeAlD
Lurasidone—HTR2A—kidney—type 2 diabetes mellitus	0.000321	0.00852	CbGeAlD
Lurasidone—ADRA2C—liver—type 2 diabetes mellitus	0.000299	0.00794	CbGeAlD
Lurasidone—CYP3A4—kidney—type 2 diabetes mellitus	0.000297	0.00789	CbGeAlD
Lurasidone—HTR2A—liver—type 2 diabetes mellitus	0.000203	0.00539	CbGeAlD
Lurasidone—CYP3A4—liver—type 2 diabetes mellitus	0.000188	0.00499	CbGeAlD
Lurasidone—Anxiety—Orlistat—type 2 diabetes mellitus	0.000113	0.00076	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000113	0.000758	CcSEcCtD
Lurasidone—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000112	0.000755	CcSEcCtD
Lurasidone—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000112	0.000753	CcSEcCtD
Lurasidone—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000112	0.000753	CcSEcCtD
Lurasidone—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000112	0.000751	CcSEcCtD
Lurasidone—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000111	0.000749	CcSEcCtD
Lurasidone—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000111	0.000746	CcSEcCtD
Lurasidone—Malaise—Metformin—type 2 diabetes mellitus	0.000111	0.000745	CcSEcCtD
Lurasidone—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000111	0.000744	CcSEcCtD
Lurasidone—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00011	0.000742	CcSEcCtD
Lurasidone—Vomiting—Glipizide—type 2 diabetes mellitus	0.00011	0.000741	CcSEcCtD
Lurasidone—Syncope—Metformin—type 2 diabetes mellitus	0.00011	0.000741	CcSEcCtD
Lurasidone—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00011	0.000739	CcSEcCtD
Lurasidone—Infection—Valsartan—type 2 diabetes mellitus	0.000109	0.000735	CcSEcCtD
Lurasidone—Rash—Glipizide—type 2 diabetes mellitus	0.000109	0.000735	CcSEcCtD
Lurasidone—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000109	0.000734	CcSEcCtD
Lurasidone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000109	0.000734	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000109	0.000734	CcSEcCtD
Lurasidone—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000109	0.000734	CcSEcCtD
Lurasidone—Tremor—Irbesartan—type 2 diabetes mellitus	0.000108	0.00073	CcSEcCtD
Lurasidone—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000108	0.000729	CcSEcCtD
Lurasidone—Shock—Valsartan—type 2 diabetes mellitus	0.000108	0.000728	CcSEcCtD
Lurasidone—Infection—Orlistat—type 2 diabetes mellitus	0.000108	0.000727	CcSEcCtD
Lurasidone—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000108	0.000726	CcSEcCtD
Lurasidone—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000108	0.000726	CcSEcCtD
Lurasidone—Flatulence—Losartan—type 2 diabetes mellitus	0.000107	0.000723	CcSEcCtD
Lurasidone—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000107	0.00072	CcSEcCtD
Lurasidone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000107	0.000719	CcSEcCtD
Lurasidone—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000107	0.000719	CcSEcCtD
Lurasidone—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000107	0.000718	CcSEcCtD
Lurasidone—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000107	0.000717	CcSEcCtD
Lurasidone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000107	0.000717	CcSEcCtD
Lurasidone—Agitation—Irbesartan—type 2 diabetes mellitus	0.000106	0.000716	CcSEcCtD
Lurasidone—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000106	0.000716	CcSEcCtD
Lurasidone—Hypertension—Metformin—type 2 diabetes mellitus	0.000106	0.000713	CcSEcCtD
Lurasidone—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000106	0.000712	CcSEcCtD
Lurasidone—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000106	0.00071	CcSEcCtD
Lurasidone—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000105	0.00071	CcSEcCtD
Lurasidone—Back pain—Losartan—type 2 diabetes mellitus	0.000105	0.000709	CcSEcCtD
Lurasidone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000105	0.000709	CcSEcCtD
Lurasidone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000105	0.000709	CcSEcCtD
Lurasidone—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000105	0.000707	CcSEcCtD
Lurasidone—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000105	0.000705	CcSEcCtD
Lurasidone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000105	0.000704	CcSEcCtD
Lurasidone—Myalgia—Metformin—type 2 diabetes mellitus	0.000104	0.000703	CcSEcCtD
Lurasidone—Malaise—Irbesartan—type 2 diabetes mellitus	0.000104	0.000703	CcSEcCtD
Lurasidone—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000104	0.0007	CcSEcCtD
Lurasidone—Syncope—Irbesartan—type 2 diabetes mellitus	0.000104	0.000699	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000104	0.000698	CcSEcCtD
Lurasidone—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000104	0.000698	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000103	0.000695	CcSEcCtD
Lurasidone—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000103	0.000695	CcSEcCtD
Lurasidone—Nausea—Glipizide—type 2 diabetes mellitus	0.000103	0.000692	CcSEcCtD
Lurasidone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000103	0.000692	CcSEcCtD
Lurasidone—Hypotension—Valsartan—type 2 diabetes mellitus	0.000103	0.000692	CcSEcCtD
Lurasidone—Vision blurred—Losartan—type 2 diabetes mellitus	0.000103	0.000691	CcSEcCtD
Lurasidone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000102	0.000689	CcSEcCtD
Lurasidone—Tremor—Losartan—type 2 diabetes mellitus	0.000102	0.000687	CcSEcCtD
Lurasidone—Rash—Glimepiride—type 2 diabetes mellitus	0.000102	0.000686	CcSEcCtD
Lurasidone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000102	0.000685	CcSEcCtD
Lurasidone—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000102	0.000685	CcSEcCtD
Lurasidone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000102	0.000684	CcSEcCtD
Lurasidone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000101	0.000683	CcSEcCtD
Lurasidone—Anaemia—Losartan—type 2 diabetes mellitus	0.000101	0.000678	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.0001	0.000674	CcSEcCtD
Lurasidone—Agitation—Losartan—type 2 diabetes mellitus	0.0001	0.000674	CcSEcCtD
Lurasidone—Hypertension—Irbesartan—type 2 diabetes mellitus	0.0001	0.000673	CcSEcCtD
Lurasidone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.98e-05	0.000671	CcSEcCtD
Lurasidone—Angioedema—Losartan—type 2 diabetes mellitus	9.96e-05	0.00067	CcSEcCtD
Lurasidone—Infection—Metformin—type 2 diabetes mellitus	9.95e-05	0.00067	CcSEcCtD
Lurasidone—Insomnia—Valsartan—type 2 diabetes mellitus	9.95e-05	0.000669	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.9e-05	0.000666	CcSEcCtD
Lurasidone—Myalgia—Irbesartan—type 2 diabetes mellitus	9.86e-05	0.000664	CcSEcCtD
Lurasidone—Shock—Metformin—type 2 diabetes mellitus	9.85e-05	0.000663	CcSEcCtD
Lurasidone—Insomnia—Orlistat—type 2 diabetes mellitus	9.83e-05	0.000661	CcSEcCtD
Lurasidone—Malaise—Losartan—type 2 diabetes mellitus	9.83e-05	0.000661	CcSEcCtD
Lurasidone—Anxiety—Irbesartan—type 2 diabetes mellitus	9.82e-05	0.000661	CcSEcCtD
Lurasidone—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.82e-05	0.000661	CcSEcCtD
Lurasidone—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.8e-05	0.00066	CcSEcCtD
Lurasidone—Vertigo—Losartan—type 2 diabetes mellitus	9.79e-05	0.000659	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	9.79e-05	0.000659	CcSEcCtD
Lurasidone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.79e-05	0.000659	CcSEcCtD
Lurasidone—Somnolence—Valsartan—type 2 diabetes mellitus	9.78e-05	0.000658	CcSEcCtD
Lurasidone—Syncope—Losartan—type 2 diabetes mellitus	9.77e-05	0.000658	CcSEcCtD
Lurasidone—Leukopenia—Losartan—type 2 diabetes mellitus	9.75e-05	0.000657	CcSEcCtD
Lurasidone—Skin disorder—Metformin—type 2 diabetes mellitus	9.73e-05	0.000655	CcSEcCtD
Lurasidone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.68e-05	0.000652	CcSEcCtD
Lurasidone—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.68e-05	0.000652	CcSEcCtD
Lurasidone—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.64e-05	0.000649	CcSEcCtD
Lurasidone—Dry mouth—Irbesartan—type 2 diabetes mellitus	9.64e-05	0.000649	CcSEcCtD
Lurasidone—Nausea—Glimepiride—type 2 diabetes mellitus	9.6e-05	0.000646	CcSEcCtD
Lurasidone—Arrhythmia—Ramipril—type 2 diabetes mellitus	9.59e-05	0.000645	CcSEcCtD
Lurasidone—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.58e-05	0.000645	CcSEcCtD
Lurasidone—Nausea—Sitagliptin—type 2 diabetes mellitus	9.57e-05	0.000644	CcSEcCtD
Lurasidone—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.57e-05	0.000644	CcSEcCtD
Lurasidone—Asthenia—Glyburide—type 2 diabetes mellitus	9.56e-05	0.000644	CcSEcCtD
Lurasidone—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.56e-05	0.000643	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.49e-05	0.000639	CcSEcCtD
Lurasidone—Fatigue—Valsartan—type 2 diabetes mellitus	9.48e-05	0.000638	CcSEcCtD
Lurasidone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.46e-05	0.000637	CcSEcCtD
Lurasidone—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.45e-05	0.000636	CcSEcCtD
Lurasidone—Pruritus—Glyburide—type 2 diabetes mellitus	9.43e-05	0.000635	CcSEcCtD
Lurasidone—Mental disorder—Ramipril—type 2 diabetes mellitus	9.4e-05	0.000633	CcSEcCtD
Lurasidone—Infection—Irbesartan—type 2 diabetes mellitus	9.39e-05	0.000632	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	9.38e-05	0.000631	CcSEcCtD
Lurasidone—Fatigue—Orlistat—type 2 diabetes mellitus	9.37e-05	0.000631	CcSEcCtD
Lurasidone—Hypotension—Metformin—type 2 diabetes mellitus	9.36e-05	0.00063	CcSEcCtD
Lurasidone—Malnutrition—Ramipril—type 2 diabetes mellitus	9.34e-05	0.000629	CcSEcCtD
Lurasidone—Shock—Irbesartan—type 2 diabetes mellitus	9.3e-05	0.000626	CcSEcCtD
Lurasidone—Myalgia—Losartan—type 2 diabetes mellitus	9.28e-05	0.000624	CcSEcCtD
Lurasidone—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.27e-05	0.000624	CcSEcCtD
Lurasidone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	9.27e-05	0.000624	CcSEcCtD
Lurasidone—Anxiety—Losartan—type 2 diabetes mellitus	9.25e-05	0.000622	CcSEcCtD
Lurasidone—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.22e-05	0.000621	CcSEcCtD
Lurasidone—Rash—Bromocriptine—type 2 diabetes mellitus	9.19e-05	0.000619	CcSEcCtD
Lurasidone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.19e-05	0.000618	CcSEcCtD
Lurasidone—Skin disorder—Irbesartan—type 2 diabetes mellitus	9.18e-05	0.000618	CcSEcCtD
Lurasidone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000615	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.12e-05	0.000614	CcSEcCtD
Lurasidone—Diarrhoea—Glyburide—type 2 diabetes mellitus	9.12e-05	0.000614	CcSEcCtD
Lurasidone—Dry mouth—Losartan—type 2 diabetes mellitus	9.07e-05	0.000611	CcSEcCtD
Lurasidone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.99e-05	0.000605	CcSEcCtD
Lurasidone—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.98e-05	0.000605	CcSEcCtD
Lurasidone—Dyspnoea—Metformin—type 2 diabetes mellitus	8.93e-05	0.000601	CcSEcCtD
Lurasidone—Somnolence—Metformin—type 2 diabetes mellitus	8.9e-05	0.000599	CcSEcCtD
Lurasidone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.89e-05	0.000598	CcSEcCtD
Lurasidone—Infection—Losartan—type 2 diabetes mellitus	8.84e-05	0.000595	CcSEcCtD
Lurasidone—Hypotension—Irbesartan—type 2 diabetes mellitus	8.83e-05	0.000594	CcSEcCtD
Lurasidone—Dyspepsia—Metformin—type 2 diabetes mellitus	8.82e-05	0.000593	CcSEcCtD
Lurasidone—Tremor—Ramipril—type 2 diabetes mellitus	8.75e-05	0.000589	CcSEcCtD
Lurasidone—Shock—Losartan—type 2 diabetes mellitus	8.75e-05	0.000589	CcSEcCtD
Lurasidone—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.72e-05	0.000587	CcSEcCtD
Lurasidone—Decreased appetite—Metformin—type 2 diabetes mellitus	8.71e-05	0.000586	CcSEcCtD
Lurasidone—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.69e-05	0.000585	CcSEcCtD
Lurasidone—Tachycardia—Losartan—type 2 diabetes mellitus	8.68e-05	0.000584	CcSEcCtD
Lurasidone—Nausea—Bromocriptine—type 2 diabetes mellitus	8.66e-05	0.000583	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.65e-05	0.000582	CcSEcCtD
Lurasidone—Fatigue—Metformin—type 2 diabetes mellitus	8.63e-05	0.000581	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.61e-05	0.00058	CcSEcCtD
Lurasidone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.6e-05	0.000579	CcSEcCtD
Lurasidone—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.59e-05	0.000578	CcSEcCtD
Lurasidone—Asthenia—Gliclazide—type 2 diabetes mellitus	8.59e-05	0.000578	CcSEcCtD
Lurasidone—Agitation—Ramipril—type 2 diabetes mellitus	8.59e-05	0.000578	CcSEcCtD
Lurasidone—Angioedema—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000575	CcSEcCtD
Lurasidone—Vomiting—Glyburide—type 2 diabetes mellitus	8.48e-05	0.00057	CcSEcCtD
Lurasidone—Pruritus—Gliclazide—type 2 diabetes mellitus	8.47e-05	0.00057	CcSEcCtD
Lurasidone—Malaise—Ramipril—type 2 diabetes mellitus	8.43e-05	0.000567	CcSEcCtD
Lurasidone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.43e-05	0.000567	CcSEcCtD
Lurasidone—Rash—Glyburide—type 2 diabetes mellitus	8.4e-05	0.000566	CcSEcCtD
Lurasidone—Somnolence—Irbesartan—type 2 diabetes mellitus	8.4e-05	0.000565	CcSEcCtD
Lurasidone—Dermatitis—Glyburide—type 2 diabetes mellitus	8.4e-05	0.000565	CcSEcCtD
Lurasidone—Vertigo—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000565	CcSEcCtD
Lurasidone—Syncope—Ramipril—type 2 diabetes mellitus	8.38e-05	0.000564	CcSEcCtD
Lurasidone—Leukopenia—Ramipril—type 2 diabetes mellitus	8.36e-05	0.000563	CcSEcCtD
Lurasidone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.32e-05	0.00056	CcSEcCtD
Lurasidone—Hypotension—Losartan—type 2 diabetes mellitus	8.31e-05	0.000559	CcSEcCtD
Lurasidone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.22e-05	0.000553	CcSEcCtD
Lurasidone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.21e-05	0.000553	CcSEcCtD
Lurasidone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.19e-05	0.000551	CcSEcCtD
Lurasidone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.19e-05	0.000551	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.16e-05	0.000549	CcSEcCtD
Lurasidone—Fatigue—Irbesartan—type 2 diabetes mellitus	8.15e-05	0.000548	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.1e-05	0.000545	CcSEcCtD
Lurasidone—Convulsion—Ramipril—type 2 diabetes mellitus	8.1e-05	0.000545	CcSEcCtD
Lurasidone—Insomnia—Losartan—type 2 diabetes mellitus	8.04e-05	0.000541	CcSEcCtD
Lurasidone—Myalgia—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000535	CcSEcCtD
Lurasidone—Dyspnoea—Losartan—type 2 diabetes mellitus	7.93e-05	0.000534	CcSEcCtD
Lurasidone—Anxiety—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000534	CcSEcCtD
Lurasidone—Nausea—Glyburide—type 2 diabetes mellitus	7.92e-05	0.000533	CcSEcCtD
Lurasidone—Abdominal pain—Metformin—type 2 diabetes mellitus	7.92e-05	0.000533	CcSEcCtD
Lurasidone—Dizziness—Gliclazide—type 2 diabetes mellitus	7.92e-05	0.000533	CcSEcCtD
Lurasidone—Somnolence—Losartan—type 2 diabetes mellitus	7.91e-05	0.000532	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.9e-05	0.000532	CcSEcCtD
Lurasidone—Asthenia—Valsartan—type 2 diabetes mellitus	7.89e-05	0.000531	CcSEcCtD
Lurasidone—Dyspepsia—Losartan—type 2 diabetes mellitus	7.83e-05	0.000527	CcSEcCtD
Lurasidone—Asthenia—Orlistat—type 2 diabetes mellitus	7.8e-05	0.000525	CcSEcCtD
Lurasidone—Pruritus—Valsartan—type 2 diabetes mellitus	7.78e-05	0.000524	CcSEcCtD
Lurasidone—Dry mouth—Ramipril—type 2 diabetes mellitus	7.78e-05	0.000524	CcSEcCtD
Lurasidone—Decreased appetite—Losartan—type 2 diabetes mellitus	7.73e-05	0.00052	CcSEcCtD
Lurasidone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.73e-05	0.00052	CcSEcCtD
Lurasidone—Pruritus—Orlistat—type 2 diabetes mellitus	7.69e-05	0.000517	CcSEcCtD
Lurasidone—Fatigue—Losartan—type 2 diabetes mellitus	7.67e-05	0.000516	CcSEcCtD
Lurasidone—Vomiting—Gliclazide—type 2 diabetes mellitus	7.61e-05	0.000512	CcSEcCtD
Lurasidone—Rash—Gliclazide—type 2 diabetes mellitus	7.55e-05	0.000508	CcSEcCtD
Lurasidone—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.54e-05	0.000507	CcSEcCtD
Lurasidone—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.52e-05	0.000506	CcSEcCtD
Lurasidone—Shock—Ramipril—type 2 diabetes mellitus	7.5e-05	0.000505	CcSEcCtD
Lurasidone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	7.48e-05	0.000503	CcSEcCtD
Lurasidone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.47e-05	0.000503	CcSEcCtD
Lurasidone—Tachycardia—Ramipril—type 2 diabetes mellitus	7.44e-05	0.000501	CcSEcCtD
Lurasidone—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.44e-05	0.0005	CcSEcCtD
Lurasidone—Skin disorder—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000499	CcSEcCtD
Lurasidone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000496	CcSEcCtD
Lurasidone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.27e-05	0.000489	CcSEcCtD
Lurasidone—Dizziness—Valsartan—type 2 diabetes mellitus	7.27e-05	0.000489	CcSEcCtD
Lurasidone—Dizziness—Orlistat—type 2 diabetes mellitus	7.19e-05	0.000484	CcSEcCtD
Lurasidone—Asthenia—Metformin—type 2 diabetes mellitus	7.19e-05	0.000484	CcSEcCtD
Lurasidone—Hypotension—Ramipril—type 2 diabetes mellitus	7.13e-05	0.00048	CcSEcCtD
Lurasidone—Nausea—Gliclazide—type 2 diabetes mellitus	7.11e-05	0.000479	CcSEcCtD
Lurasidone—Pruritus—Metformin—type 2 diabetes mellitus	7.09e-05	0.000477	CcSEcCtD
Lurasidone—Abdominal pain—Losartan—type 2 diabetes mellitus	7.03e-05	0.000473	CcSEcCtD
Lurasidone—Vomiting—Valsartan—type 2 diabetes mellitus	6.99e-05	0.000471	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.95e-05	0.000468	CcSEcCtD
Lurasidone—Rash—Valsartan—type 2 diabetes mellitus	6.93e-05	0.000467	CcSEcCtD
Lurasidone—Dermatitis—Valsartan—type 2 diabetes mellitus	6.93e-05	0.000466	CcSEcCtD
Lurasidone—Vomiting—Orlistat—type 2 diabetes mellitus	6.91e-05	0.000465	CcSEcCtD
Lurasidone—Insomnia—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000464	CcSEcCtD
Lurasidone—Diarrhoea—Metformin—type 2 diabetes mellitus	6.85e-05	0.000461	CcSEcCtD
Lurasidone—Rash—Orlistat—type 2 diabetes mellitus	6.85e-05	0.000461	CcSEcCtD
Lurasidone—Dermatitis—Orlistat—type 2 diabetes mellitus	6.85e-05	0.000461	CcSEcCtD
Lurasidone—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000458	CcSEcCtD
Lurasidone—Asthenia—Irbesartan—type 2 diabetes mellitus	6.78e-05	0.000456	CcSEcCtD
Lurasidone—Somnolence—Ramipril—type 2 diabetes mellitus	6.78e-05	0.000456	CcSEcCtD
Lurasidone—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.71e-05	0.000452	CcSEcCtD
Lurasidone—Pruritus—Irbesartan—type 2 diabetes mellitus	6.69e-05	0.00045	CcSEcCtD
Lurasidone—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.63e-05	0.000446	CcSEcCtD
Lurasidone—Dizziness—Metformin—type 2 diabetes mellitus	6.62e-05	0.000446	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.58e-05	0.000443	CcSEcCtD
Lurasidone—Fatigue—Ramipril—type 2 diabetes mellitus	6.58e-05	0.000443	CcSEcCtD
Lurasidone—Nausea—Valsartan—type 2 diabetes mellitus	6.53e-05	0.00044	CcSEcCtD
Lurasidone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.47e-05	0.000435	CcSEcCtD
Lurasidone—Nausea—Orlistat—type 2 diabetes mellitus	6.45e-05	0.000434	CcSEcCtD
Lurasidone—Asthenia—Losartan—type 2 diabetes mellitus	6.38e-05	0.000429	CcSEcCtD
Lurasidone—Vomiting—Metformin—type 2 diabetes mellitus	6.37e-05	0.000429	CcSEcCtD
Lurasidone—Rash—Metformin—type 2 diabetes mellitus	6.31e-05	0.000425	CcSEcCtD
Lurasidone—Dermatitis—Metformin—type 2 diabetes mellitus	6.31e-05	0.000425	CcSEcCtD
Lurasidone—Pruritus—Losartan—type 2 diabetes mellitus	6.29e-05	0.000424	CcSEcCtD
Lurasidone—Dizziness—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000421	CcSEcCtD
Lurasidone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.24e-05	0.00042	CcSEcCtD
Lurasidone—Diarrhoea—Losartan—type 2 diabetes mellitus	6.09e-05	0.00041	CcSEcCtD
Lurasidone—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.03e-05	0.000406	CcSEcCtD
Lurasidone—Vomiting—Irbesartan—type 2 diabetes mellitus	6.01e-05	0.000404	CcSEcCtD
Lurasidone—Rash—Irbesartan—type 2 diabetes mellitus	5.96e-05	0.000401	CcSEcCtD
Lurasidone—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.95e-05	0.000401	CcSEcCtD
Lurasidone—Nausea—Metformin—type 2 diabetes mellitus	5.95e-05	0.0004	CcSEcCtD
Lurasidone—Dizziness—Losartan—type 2 diabetes mellitus	5.88e-05	0.000396	CcSEcCtD
Lurasidone—Vomiting—Losartan—type 2 diabetes mellitus	5.66e-05	0.000381	CcSEcCtD
Lurasidone—Nausea—Irbesartan—type 2 diabetes mellitus	5.61e-05	0.000378	CcSEcCtD
Lurasidone—Rash—Losartan—type 2 diabetes mellitus	5.61e-05	0.000377	CcSEcCtD
Lurasidone—Dermatitis—Losartan—type 2 diabetes mellitus	5.6e-05	0.000377	CcSEcCtD
Lurasidone—Asthenia—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000368	CcSEcCtD
Lurasidone—Pruritus—Ramipril—type 2 diabetes mellitus	5.4e-05	0.000363	CcSEcCtD
Lurasidone—Nausea—Losartan—type 2 diabetes mellitus	5.28e-05	0.000356	CcSEcCtD
Lurasidone—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000351	CcSEcCtD
Lurasidone—Dizziness—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000339	CcSEcCtD
Lurasidone—Vomiting—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000326	CcSEcCtD
Lurasidone—Rash—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000324	CcSEcCtD
Lurasidone—Dermatitis—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000323	CcSEcCtD
Lurasidone—Nausea—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000305	CcSEcCtD
Lurasidone—ADRA2A—Metabolism—MTHFR—type 2 diabetes mellitus	5.23e-06	7.48e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.23e-06	7.48e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PPARG—type 2 diabetes mellitus	5.22e-06	7.47e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.22e-06	7.47e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.2e-06	7.44e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	5.18e-06	7.41e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	5.18e-06	7.41e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.16e-06	7.39e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.13e-06	7.35e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PPARA—type 2 diabetes mellitus	5.13e-06	7.34e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.12e-06	7.33e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—INS—type 2 diabetes mellitus	5.12e-06	7.33e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.12e-06	7.33e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AGT—type 2 diabetes mellitus	5.12e-06	7.32e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.1e-06	7.31e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.1e-06	7.31e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.1e-06	7.31e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.1e-06	7.31e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—AKT1—type 2 diabetes mellitus	5.09e-06	7.29e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.09e-06	7.29e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APOB—type 2 diabetes mellitus	5.09e-06	7.28e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.07e-06	7.25e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.03e-06	7.2e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—LEP—type 2 diabetes mellitus	5.01e-06	7.17e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—APOE—type 2 diabetes mellitus	5.01e-06	7.17e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.01e-06	7.17e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.01e-06	7.16e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5e-06	7.15e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—AGT—type 2 diabetes mellitus	4.97e-06	7.11e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.95e-06	7.09e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—RELA—type 2 diabetes mellitus	4.93e-06	7.05e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.92e-06	7.04e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.89e-06	7e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CALM1—type 2 diabetes mellitus	4.89e-06	6.99e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	4.88e-06	6.99e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.88e-06	6.99e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—APOE—type 2 diabetes mellitus	4.87e-06	6.97e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—LPL—type 2 diabetes mellitus	4.86e-06	6.95e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—APOA1—type 2 diabetes mellitus	4.81e-06	6.89e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—C3—type 2 diabetes mellitus	4.81e-06	6.88e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.75e-06	6.8e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.73e-06	6.76e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—ALB—type 2 diabetes mellitus	4.69e-06	6.72e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.66e-06	6.67e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.65e-06	6.65e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	4.64e-06	6.64e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.62e-06	6.61e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.58e-06	6.56e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.57e-06	6.54e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AGT—type 2 diabetes mellitus	4.57e-06	6.54e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.56e-06	6.53e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.56e-06	6.52e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.55e-06	6.51e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.55e-06	6.51e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.55e-06	6.51e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.5e-06	6.43e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PIK3R1—type 2 diabetes mellitus	4.49e-06	6.43e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—NOS3—type 2 diabetes mellitus	4.49e-06	6.43e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.49e-06	6.43e-05	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.49e-06	6.42e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	4.47e-06	6.4e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	4.47e-06	6.4e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.47e-06	6.4e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.47e-06	6.4e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.45e-06	6.36e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	4.42e-06	6.33e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.42e-06	6.33e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.42e-06	6.32e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	4.37e-06	6.26e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.35e-06	6.23e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.29e-06	6.14e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—INS—type 2 diabetes mellitus	4.28e-06	6.13e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.28e-06	6.13e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.28e-06	6.12e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.26e-06	6.1e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.25e-06	6.08e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	4.24e-06	6.07e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.22e-06	6.04e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.21e-06	6.03e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.2e-06	6.01e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.17e-06	5.97e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.16e-06	5.96e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.16e-06	5.96e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.16e-06	5.95e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	4.16e-06	5.95e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.16e-06	5.95e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	4.15e-06	5.95e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.14e-06	5.93e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.14e-06	5.92e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	4.14e-06	5.92e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.12e-06	5.9e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PTGS2—type 2 diabetes mellitus	4.11e-06	5.88e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.09e-06	5.85e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.08e-06	5.84e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.07e-06	5.83e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	4.07e-06	5.83e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	4.07e-06	5.83e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.06e-06	5.82e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.06e-06	5.81e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.05e-06	5.8e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.05e-06	5.8e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.05e-06	5.8e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.03e-06	5.77e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.02e-06	5.76e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.99e-06	5.71e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.96e-06	5.66e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.93e-06	5.63e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.91e-06	5.6e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	3.88e-06	5.56e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.88e-06	5.55e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.88e-06	5.55e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—SRC—type 2 diabetes mellitus	3.87e-06	5.54e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.84e-06	5.49e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	3.82e-06	5.47e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.82e-06	5.47e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	3.81e-06	5.46e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.77e-06	5.4e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.76e-06	5.38e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.76e-06	5.38e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.75e-06	5.37e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.75e-06	5.37e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.75e-06	5.37e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.74e-06	5.35e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.7e-06	5.29e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.69e-06	5.29e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.68e-06	5.27e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	3.65e-06	5.23e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	3.65e-06	5.22e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	3.65e-06	5.22e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.64e-06	5.21e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.64e-06	5.21e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.64e-06	5.21e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.63e-06	5.2e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.57e-06	5.11e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.57e-06	5.11e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.54e-06	5.06e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	3.53e-06	5.06e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.51e-06	5.03e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	3.48e-06	4.98e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.46e-06	4.96e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.46e-06	4.96e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.42e-06	4.9e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.41e-06	4.88e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.41e-06	4.88e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.39e-06	4.86e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.36e-06	4.81e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.36e-06	4.81e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.35e-06	4.8e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.35e-06	4.8e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.35e-06	4.79e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	3.34e-06	4.77e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.33e-06	4.76e-05	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.33e-06	4.76e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.29e-06	4.71e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.29e-06	4.71e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.29e-06	4.71e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.27e-06	4.68e-05	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.22e-06	4.6e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.21e-06	4.59e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.19e-06	4.57e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.19e-06	4.56e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.17e-06	4.53e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	3.16e-06	4.52e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.15e-06	4.51e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.15e-06	4.51e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.11e-06	4.46e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.08e-06	4.41e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.05e-06	4.36e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.05e-06	4.36e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.02e-06	4.32e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.01e-06	4.31e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.98e-06	4.27e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.92e-06	4.18e-05	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.92e-06	4.18e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.89e-06	4.14e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.87e-06	4.11e-05	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.87e-06	4.11e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.87e-06	4.11e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.87e-06	4.11e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.85e-06	4.07e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.83e-06	4.05e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.8e-06	4e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	2.78e-06	3.97e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.73e-06	3.91e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.72e-06	3.89e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.72e-06	3.89e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.71e-06	3.87e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.71e-06	3.87e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.7e-06	3.87e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.69e-06	3.85e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.67e-06	3.82e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.66e-06	3.81e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.65e-06	3.79e-05	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.61e-06	3.74e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	2.61e-06	3.73e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.61e-06	3.73e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.59e-06	3.71e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.59e-06	3.71e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.57e-06	3.68e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.57e-06	3.67e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.52e-06	3.61e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.52e-06	3.61e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.52e-06	3.6e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.48e-06	3.55e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.48e-06	3.55e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.47e-06	3.54e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.45e-06	3.51e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.45e-06	3.5e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.43e-06	3.48e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.42e-06	3.47e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.42e-06	3.46e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.42e-06	3.46e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.41e-06	3.46e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.41e-06	3.44e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.37e-06	3.4e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.35e-06	3.36e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.32e-06	3.32e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.26e-06	3.23e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.25e-06	3.22e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.23e-06	3.19e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.22e-06	3.17e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.21e-06	3.16e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.2e-06	3.14e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.19e-06	3.13e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.17e-06	3.11e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.12e-06	3.03e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.08e-06	2.98e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.07e-06	2.97e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	2.06e-06	2.95e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.05e-06	2.93e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.02e-06	2.89e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.98e-06	2.83e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.93e-06	2.77e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1.87e-06	2.68e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.81e-06	2.59e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.78e-06	2.55e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.77e-06	2.54e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.73e-06	2.47e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.7e-06	2.43e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	1.68e-06	2.4e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.67e-06	2.39e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.62e-06	2.32e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.57e-06	2.24e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.55e-06	2.22e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.55e-06	2.22e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.54e-06	2.21e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.52e-06	2.17e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.42e-06	2.03e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.4e-06	2.01e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.14e-07	1.02e-05	CbGpPWpGaD
